CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award SVP - New Bus Dev & Spec Sales acquired 6,625 shares (grant or award)
- 4 Grant or award President and CEO acquired 23,750 shares (grant or award)
- 4 Grant or award SVP Ops & Prod Dev acquired 3,625 shares (grant or award)
- 4 Grant or award Vice President and CFO acquired 6,625 shares (grant or award)
- 4 Exercise or conversion Director acquired 5,458 shares (option exercise)
- 4 Open-market sale President and CEO sold 37,455 shares at $66.97 ($2,508,361)
- 4 Open-market sale VP Bus Dev & Con Mfg sold 12,500 shares at $67.06 ($838,209)
- 4 Gift President and CEO gave 836 shares (gift)
- 4 Shares withheld for taxes President and CEO gave up 991 shares (to pay taxes)
- 4 Shares withheld for taxes VP Bus Dev & Con Mfg gave up 450 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes President and CEO gave up 1,161 shares (to pay taxes)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Vice President and CFO acquired 4,200 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
Page 24 of 42 · 835 filings